Jonathan Biller Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Jonathan Biller has an estimated net worth of at least $10.6 million*, as of Oct. 29, 2025. They own 13,659 shares of VRTX stock. They have sold 17,056 shares of VRTX stock since 2021, for an estimated $4.0 million.
Jonathan Biller $VRTX SEC Form 4 Insider Trading
Jonathan Biller has filed a total of 12 insider trades in $VRTX since 2021. Their most recent trade was a sale of 945 shares, made on Feb 25, 2026. Their largest trade was a sale of 3,433 shares, made on Feb 11, 2025. We estimate that they now own 13,659 shares of $VRTX, worth an estimated $6.5 million.
Insider Trading at $VRTX
There have been a total of 559 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 2,329 shares reported by Carmen Bozic (EVP and CMO), made on Feb 27, 2026.
History of Insider Stock Trades by Jonathan Biller
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 945 | Feb 25, 2026 | Feb. 26, 2026, 7:01 p.m. |
|
VRTX
|
Sale | 1,244 | Feb 18, 2026 | Feb. 19, 2026, 5:08 p.m. |
|
VRTX
|
Sale | 2,476 | Feb 17, 2026 | Feb. 19, 2026, 5:08 p.m. |
|
VRTX
|
Sale | 988 | Feb 13, 2026 | Feb. 18, 2026, 5:26 p.m. |
|
VRTX
|
Sale | 1,925 | Feb 11, 2026 | Feb. 12, 2026, 5:52 p.m. |
|
VRTX
|
Sale | 347 | Dec 03, 2025 | Dec. 5, 2025, 5:06 p.m. |
|
VRTX
|
Sale | 694 | Oct 02, 2025 | Oct. 3, 2025, 4:07 p.m. |
|
VRTX
|
Sale | 1,657 | Feb 18, 2025 | Feb. 19, 2025, 5:28 p.m. |
|
VRTX
|
Sale | 3,433 | Feb 11, 2025 | Feb. 12, 2025, 5:36 p.m. |
|
VRTX
|
Sale | 999 | Oct 02, 2024 | Oct. 3, 2024, 4:12 p.m. |
|
VRTX
|
Sale | 1,738 | Feb 12, 2024 | Feb. 13, 2024, 5:56 p.m. |
|
VRTX
|
Sale | 610 | Oct 02, 2023 | Oct. 3, 2023, 4:07 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Stuart A Arbuckle, EVP, COO
-
Jeffrey M Leiden, Executive Chairman
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Carmen Bozic, EVP and CMO
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
-
Mark E. Bunnage, EVP, Chief Scientific Officer
-
Amit Sachdev, EVP, Chief Patient Officer
-
Charles F Jr Wagner, EVP, CO & FO
-
Duncan Mckechnie, EVP, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.